Complicated Skin and Soft Tissue Infection
📧 Sign up to get email alerts when something new happens for Complicated Skin and Soft Tissue Infection.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-10-22EMA Authorised: Tygacil (tigecycline) — Pfizer Europe MA EEIG
The European Medicines Agency authorised Tygacil (tigecycline) for use in bacterial infections, including complicated skin and soft tissue i…
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries
A retrospective chart review study assessing characteristics, treatment outcomes, and resource use for adults hospitalized with community-ac…
-
FDA approval · 2022-08-18FDA Approved: MEROPENEM — Original Application (BROOKS STERISCIENCE LIMITED)
FDA approves Brooks SterisScience Limited's original application for generic meropenem (Meropenem) for multiple susceptible bacterial infect…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections. [Phase 3]
Phase 3 trial evaluating ceftaroline fosamil versus vancomycin plus aztreonam for complicated skin and soft tissue infections; trial termina…
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections [Phase 3]
Phase 3 trial evaluating ceftaroline fosamil versus vancomycin plus aztreonam in complicated skin and soft tissue infections has completed w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-01-11Clinical Trial Update: Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) [Phase 2]
A Phase 2 trial comparing TD-6424 (telavancin) to standard therapy for complicated Gram-positive skin and skin structure infections has comp…
-
CLINICAL_TRIALS trial_result · 2010-01-11Clinical Trial Update: Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection [Phase 3]
Phase 3 trial comparing sequential IV/PO moxifloxacin with IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in complica…
-
CLINICAL_TRIALS trial_result · 2008-04-04Clinical Trial Update: Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1) [Phase 3]
A Phase 3 safety and efficacy trial (ASSIST-1) comparing iclaprim to linezolid for complicated skin and soft tissue infection has completed.